Vomiting, abdominal pain, compulsive bathing - Dx?

Journal of Family Practice

Volumn 63, Issue 5, 2014, Pages 257-259

  Swanson, Matthew ^a   Epperly, Ted ^b  

^a Mountain Area Health Education Center   (United States)

^b Family Medicine Residency of Idaho ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS; HYDROMORPHONE; LORAZEPAM; METOCLOPRAMIDE; ONDANSETRON; PARACETAMOL; PROMETHAZINE;

ADULT; ARTICLE; BACTERIUM CULTURE; BATH; CANNABINOID HYPEREMESIS; CANNABIS SMOKING; CASE REPORT; CHILL; CHLAMYDIA; COMPULSION; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE DURATION; ECHOGRAPHY; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; FLANK PAIN; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; LOSS OF APPETITE; LOWER ABDOMINAL PAIN; MULTIPARA; NIGHT SWEAT; PREGNANT WOMAN; URINARY URGENCY; UTERUS; VOMITING;

ADULT; BATHS; CANNABINOID RECEPTOR AGONISTS; COMPULSIVE BEHAVIOR; DRONABINOL; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; MARIJUANA SMOKING; PREGNANCY;

EID: 84899813839     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ACOG Committee on Obstetric Practice. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol. 2004;104:647-651.
2. Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53:1566-1570.
3. Sontineni SP, Chaudhary S, Sontineni V, et al. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009;15:1264-1266.
4. de Moore GM, Baker J, Bui T. Psychogenic vomiting complicated by marijuana abuse and spontaneous pneumomediastinum. Aust N Z J Psychiatry. 1996;30:290-294.
5. Smith DW, Clarren SK, Harvey MA. Hyperthermia as a possible teratogenic agent. J Pediatr. 1978;92:878-883.
6. Shiota K. Neural tube defects and maternal hyperthermia in early pregnancy: epidemiology in a human embryo population. Am J Med Genet. 1982;12:281-288.
7. Milunsky A, Ulcickas M, Rothman K, et al. Maternal heat exposure and neural tube defects. JAMA. 1992;268:882-885.
8. Miller P, Smith DW, Shepard TH. Maternal hyperthermia as a possible cause of anencephaly. Lancet. 1978;11:1519-1521.
9. Substance Abuse and Mental Health Services Administration Web site. Results from the 2008 National Survey on Drug Use and Health: national findings. Available at: http://www.samhsa.gov/data/nsduh/2k8nsduh/2k8Results.htm. Accessed December 15, 2011.
10. Gray TR, Eiden RD, Leonard KD, et al. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem. 2010;56:1442-1450.
11. Izzo AA, Coutts AA. Cannabinoids and the digestive tract. Handb Exp Pharmacol. 2005;(168):573-598.
12. McCallum RW, Soykan I, Sridhar KR, et al. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther. 1999;13:77-80.
13. Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther. 1997;74:129-180.
14. Childers SR, Breivogel CS. Cannabis and endogenous cannabinoid systems. Drug Alcohol Dependence. 1998;51:173-187.
15. Herkenham M, Lynn AB, Little MD, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci. 1990;87:1932-1936.
16. .Bergman U, Rosa FW, Baum C, et al. Effects of exposure to benzodiazepine during fetal life. Lancet. 1992;340:694-696.
17. Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Australas Psychiatry. 2007;15:156-158.